Testing a Gender-inclusive HIV Prevention Program

ConditionHIV Prevention

Trial statusRecruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexMale

Age14-18

SponsorCenter for Innovative Public Health Research

About this trial

If, over time, data suggest the intervention impacts HIV preventive behavior at the population level, it will be unique in that it can be quickly and cost effectively scaled up to impact thousands of trans girls and nonbinary youth assigned male at birth.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

assigned male sex at birth and currently have a non-cisgender identity (e.g., transgender girl, non-binary, gender fluid, unsure);

aged 14-18 years and have not yet graduated high school;

English-speaking;

the sole user of a cell phone with an unlimited text messaging plan;

Disqualifiers

None beyond not meeting inclusion criteria

Trial design

Design model

Parallel

Treatments tested in this trial

Transcendent Health
Behavioral
Gender-inclusive HIV prevention program: Text messaging-based program that lasts 5 months. Content includes information, motivation and behavioral skills about how to prevent HIV, as well as information about healthy and unhealthy romantic relationships, and navigating issues related to one\'s gender.
Text Messaging with Information
Behavioral
Text messaging-based program that lasts 5 months. Content includes information about HIV prevention and aspects of a healthy adolescent lifestyle (e.g., self-esteem).

Treatment groups

200 Participants

are divided into 2 treatment groups

Group A: Information, Motivation and Skills armExperimental treatment 1 intervention

Group B: Information Only armPlacebo comparator 1 intervention

Trial outcomes

Primary outcomes

Number testing for HIV and/or sexual transmitted infections

Self report of having been tested for either HIV or a sexually transmitted infection

Time frame

At any time after baseline through 8-months.

Secondary outcomes

Number Taking PreExposure Prophylaxis (PrEP) for HIV

Self-report of taking PrEP at any time since the prior assessment.

Time frame

At any time after baseline through 8-months.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Center for Innovative Public Health Research

Lead sponsor

University of Miami

Collaborator

Ann & Robert H Lurie Children's Hospital of Chicago